CMS Ventures — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

CC Bioccbio.co.ukJan 2026

CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision.

BiotechHealthtechMedical Devices

Dr Matthew Cummings(Co-Founder, CC Bio)Dr David Corcoran(Co-Founder, CC Bio)

Co-investorsDeep Science Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.